Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-initiated, Pragmatic, Registry-based, Multi-centre, Double-blind, Randomised Controlled Trial Evaluating the Effect of Plasmalyte Versus 0.9% Saline on Early Kidney Transplant Function in Deceased Donor Kidney Transplantation

NCT03829488 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT03829488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-initiated, Pragmatic, Registry-based, Multi-centre, Double-blind, Randomised Controlled Trial Evaluating the Effect of Plasmalyte Versus 0.9% Saline on Early Kidney Transplant Function in Deceased Donor Kidney Transplantation
Lead sponsor
The University of Queensland
Phase
Phase 3
Overall status
Completed
Start date
January 26, 2018
Completion date
May 3, 2022
Enrollment
808 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

delayed graft function, end stage kidney disease, kidney transplant; complications